性别差异:美国多中心大型研究中女性肝细胞癌的特征
这项美国5中心回顾性队列纳入2000年1月至2014年6月诊断的5327例肝细胞癌患者,其中女性1203例(22.6%)。女性非酒精性脂肪性肝病比例更高(23% vs 12%)、酒精性肝病更低(5% vs 15%),非肝硬化肝细胞癌比例更高(17% vs 10%),分期更早且总生存更长(2.5±2.9年 vs 2.2±2.7年,P=0.0031)。
要点
- 女性肝细胞癌中非酒精性脂肪性肝病相关比例显著高于男性(23% vs 12%)。
- 女性非肝硬化肝细胞癌比例更高(17% vs 10%,P<0.0001)。
- 女性就诊时分期更早、符合米兰标准比例更高且总生存更长。
核心结论
- 女性肝细胞癌患者中非酒精性脂肪性肝病和非肝硬化肝细胞癌比例显著高于男性。
- 女性就诊时肿瘤分期更早且总生存更长。
研究设计与样本
- 美国5个大型中心回顾性队列,纳入2000年1月至2014年6月诊断的肝细胞癌患者共5327例,女性1203例(22.6%)。
- 手工提取临床信息、肿瘤特征和生存数据,并按已发表标准评估是否存在肝硬化。
主要发现
- 两性肝病病因构成差异显著(P<0.0001):女性非酒精性脂肪性肝病23% vs 男性12%,酒精性肝病5% vs 15%。
- 女性非肝硬化肝细胞癌比例为17%,男性为10%(P<0.0001)。
- 女性就诊时TNM分期更早(P<0.0001),符合米兰标准比例更高(39% vs 35%,P=0.002)。
- 女性总生存长于男性(2.5±2.9年 vs 2.2±2.7年,P=0.0031)。
关键数值与推荐
- 肝细胞癌在全球癌症相关死亡中居第四位,男女比例约4:1。
- 本队列女性占22.6%(1203/5327)。
- 女性符合米兰标准者占39%,男性占35%(P=0.002)。
临床怎么用
- 对女性肝细胞癌患者应关注非酒精性脂肪性肝病相关病因及非肝硬化背景下发病的可能。
- 女性患者就诊时分期相对更早、预后相对更好,但仍需按分期规范评估与治疗。
局限性
- 原文摘要未报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer-related death worldwide, affecting men to women at a ratio of about 4:1. Risk factors, characteristics, and outcomes for HCC in women in the United States remain poorly understood; therefore, we aim to explore gender differences further. METHODS: Patients diagnosed with HCC between January 2000 and June 2014 at 5 large centers were identified. Clinical information, tumor characteristics, and survival data were extracted manually. The presence of underlying cirrhosis was assessed based on published criteria. RESULTS: Of 5,327 patients with HCC in our cohort, 1,203 (22.6%) were women. There were important differences in the underlying etiology of liver disease between the 2 genders (P < 0.0001): women had a significantly higher frequency of nonalcoholic fatty liver disease (23% vs 12%) and lower frequency of alcoholic liver disease (5% vs 15%). The proportion of noncirrhotic HCC was significantly higher among women (17% vs 10%, P < 0.0001). Women had less-advanced HCC at presentation by tumor, node, metastasis staging (P < 0.0001) and a higher proportion within Milan criteria (39% vs 35%, P = 0.002). Women had a greater overall survival (2.5 ± 2.9 years vs 2.2 ± 2.7 years, P = 0.0031). DISCUSSION: The frequency of underlying nonalcoholic fatty liver disease and noncirrhotic HCC were significantly higher in women than men in this large cohort. Women presented with less-advanced HCC and had a greater overall survival. Further investigation is warranted to explore potential mechanisms and implications for these gender differences, especially with noncirrhotic HCC (see Visual Abstract, Supplementary Digital Content 1, http://links.lww.com/AJG/B535).
引用
- Phipps M, Livanos A, Guo A, et al. Gender Matters: Characteristics of Hepatocellular Carcinoma in Women From a Large, Multicenter Study in the United States. Am J Gastroenterol. 2020. PMID: 32453046. doi:10.14309/ajg.0000000000000643
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。